![]() | Up a level |
Piazzese, Concetta, Foley, Kieran, Whybra, Philip, Hurt, Chris, Crosby, Tom and Spezi, Emiliano
2019.
Discovery of stable and prognostic CT-based radiomic features independent of contrast administration and dimensionality in oesophageal cancer.
PLoS ONE
14
(11)
, e0225550.
10.1371/journal.pone.0225550
![]() |
![]() |
Foley, Kieran, Whybra, Philip, Kalendralis, P, Larue, R, Berbee, M, Sosef, M, Parkinson, Craig, Staffurth, John, Crosby, Thomas, Roberts, S, Dekker, A, Wee, L and Spezi, Emiliano 2019. External validation of a prognostic model incorporating quantitative PET image features in esophageal cancer. Radiotherapy and Oncology 133 , pp. 205-212. 10.1016/j.radonc.2018.10.033 |
|
Wills, Lucy, Maggs, Rhydian, Lewis, Geraint, Jones, Gareth, Nixon, Lisette Sheena, Staffurth, John Nicholas and Crosby, Thomas 2017. Quality assurance of the SCOPE 1 trial in oesophageal radiotherapy. Radiation Oncology 12 (1) , 179. 10.1186/s13014-017-0916-7 |
![]() |
Cox, Samantha, Hurt, Christopher, Grenader, Tal, Mukherjee, Somnath, Bridgewater, John and Crosby, Thomas 2017. The prognostic value of derived neutrophil to lymphocyte ratio in oesophageal cancer treated with definitive chemoradiotherapy. Radiotherapy and Oncology 125 (1) , pp. 154-159. 10.1016/j.radonc.2017.08.023 |
|
Gwynne, Sarah, Jones, Gareth, Maggs, Rhydian, Eaton, David, Miles, Elizabeth, Staffurth, John, Nixon, Lisette, Ray, Ruby, Lewis, Geraint, Crosby, Thomas and Spezi, Emiliano 2016. Prospective review of radiotherapy trials through implementation of standardised multi-centre workflow and IT infrastructure. British Journal of Radiology 89 (1064) , 20160020. 10.1259/bjr.20160020 |
|
Crosby, Thomas David Lewis, Hurt, Chris Nicholas, Falk, Stephen, Gollins, Simon, Mukherjee, Somnath, Staffurth, John Nicholas, Ray, Ruby, Bashir, Nadim, Bridgewater, John A., Geh, J. Ian, Cunningham, David, Blazeby, Jane, Roy, Rajarshi, Maughan, Timothy Stanley and Griffiths, Gareth O. 2013. Chemoradiotherapy with or without cetuximab in patients with oesophageal cancer (SCOPE1): a multicentre, phase 2/3 randomised trial. The Lancet Oncology 14 (7) , pp. 627-637. 10.1016/S1470-2045(13)70136-0 |
|
Mukherjee, Somnath, Hurt, Chris Nicholas, Bridgewater, John, Falk, Stephen, Cummins, Sebastian, Wasan, Harpreet, Crosby, Thomas David Lewis, Jephcott, Catherine, Roy, Rajarshi, Radhakrishna, Ganesh, McDonald, Alec, Ray, Ruby, Joseph, George, Staffurth, John Nicholas, Abrams, Ross A., Griffiths, Gareth O. and Maughan, Timothy Stanley 2013. Gemcitabine-based or capecitabine-based chemoradiotherapy for locally advanced pancreatic cancer (SCALOP): a multicentre, randomised, phase 2 trial. The Lancet Oncology 14 (4) , pp. 317-326. 10.1016/S1470-2045(13)70021-4 |
|
Gwynne, Sarah Helene, Spezi, Emiliano, Wills, Lucy, Nixon, Lisette Sheena, Hurt, Chris Nicholas, Joseph, George, Evans, Mererid, Griffiths, Gareth O., Crosby, Thomas David Lewis and Staffurth, John Nicholas 2012. Toward semi-automated assessment of target volume delineation in radiotherapy trials: the SCOPE 1 pretrial test case. International Journal of Radiation Oncology*Biology*Physics 84 (4) , pp. 1037-1042. 10.1016/j.ijrobp.2012.01.094 |
![]() |
Gwynne, Sarah Helene, Hurt, Chris Nicholas, Evans, M., Holden, C., Vout, Lauren and Crosby, Thomas David Lewis 2011. Definitive Chemoradiation for Oesophageal Cancer - A Standard of Care in Patients with Non-metastatic Oesophageal Cancer. Clinical Oncology 23 (3) , pp. 182-188. 10.1016/j.clon.2010.12.001 |
![]() |
Hudson, E., Hurt, Chris Nicholas, Mort, D., Brewster, A. E., Iqbal, N., Joseph, George, Crosby, Thomas David Lewis and Mukherjee, Saptarshi 2010. Induction chemotherapy followed by chemoradiation in locally advanced pancreatic cancer: an effective and well-tolerated treatment. Clinical Oncology 22 (1) , pp. 27-35. 10.1016/j.clon.2009.09.024 |
![]() |
Morgan, M. A., Lewis, Wyn G., Casbard, Angela C., Roberts, S. A., Adams, Richard Alexander, Clark, Geoffrey William Barton, Havard, T. J. and Crosby, Thomas David Lewis 2009. Stage-for-stage comparison of definitive chemoradiotherapy, surgery alone and neoadjuvant chemotherapy for oesophageal carcinoma. British Journal of Surgery 96 (11) , pp. 1300-1307. 10.1002/bjs.6705 |
![]() |
Wills, Lucy, Millin, Anthony, Paterson, Jennifer, Crosby, Thomas David Lewis and Staffurth, John Nicholas 2009. The effect of planning algorithms in oesophageal radiotherapy in the context of the SCOPE 1 trial. Radiotherapy and Oncology 93 (3) , pp. 462-467. 10.1016/j.radonc.2009.08.036 |
![]() |
Abram, W. P., Clarke, J., McAleer, J. J., Graham, J. D., Riddle, P., Goodman, S., Tomlinson, M., Benstead, K., Counsell, R., Elyan, S. A., Owen, J. R., Lavery, B., Sugden, E., Dobbs, J., Whittaker, D., Brammer, C., Churn, M., Adamson, J., Dewar, J. A., Morgan, D. A., Barrett, J. M., Charlton, C. D., Bliss, P., Goodman, A., Holmes, A., Hong, A., Neal, A., Ross, G., Rostom, A., Tait, D., Yarnold, J. R., Ross, G., Illsley, M., Laing, R., Neal, A., Topham, C., Whittaker, S., Trask, C., Goodman, A. G., Barrett-Lee, Peter, Crosby, Thomas David Lewis, Gaffney, Chris C., Tilsley, David William Owen, Barrett, A., Armitage, M., Bentzen, S. M., Chetty, U., Mayles, P., Walker, L., Lucraft, H., Parmar, M., Turesson, I., Carling, M., Pritchard, J., King, M., Parkin, E., Law, K., Perkins, S. and Wells, U. 2008. The UK Standardisation of Breast Radiotherapy (START) Trial A of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial. The Lancet Oncology 9 (4) , pp. 331-341. 10.1016/S1470-2045(08)70077-9 |
![]() |
Mukherjee, Saptarshi, Hudson, E., Reza, S., Thomas, M., Crosby, Thomas David Lewis and Maughan, Timothy Stanley 2008. Pancreatic cancer within a UK cancer network with special emphasis on locally advanced non-metastatic pancreatic cancer. Clinical Oncology 20 (7) , pp. 535-540. 10.1016/j.clon.2008.02.003 |
![]() |
Crosby, Thomas David Lewis, Brewster, A. E., Borley, A., Perschky, L., Kehagioglou, Pinelopi, Court, J. and Maughan, Timothy Stanley 2004. Definitive chemoradiation in patients with inoperable oesophageal carcinoma. British Journal of Cancer 90 (1) , pp. 70-75. 10.1038/sj.bjc.6601461 |
![]() |